Inozyme Pharma, Inc.
Disclosed SEC business address
321 SUMMER STREET, SUITE 400, BOSTON, MA, 02210
Inozyme Pharma, Inc. (ticker CIK0001693011, CIK 0001693011) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 1 free company deep view left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-01T08:18:01.472384+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-01T08:18:05.569158+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-01T08:18:09.798646+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-01T08:17:59.414560+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.